| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 16 | 2023 | 509 | 2.120 |
Why?
|
| Echocardiography, Doppler | 10 | 2018 | 133 | 1.300 |
Why?
|
| Heart Ventricles | 13 | 2023 | 266 | 1.230 |
Why?
|
| Ventricular Function, Left | 10 | 2019 | 275 | 1.120 |
Why?
|
| Ventricular Dysfunction, Left | 11 | 2020 | 168 | 1.120 |
Why?
|
| Sepsis | 2 | 2019 | 291 | 0.880 |
Why?
|
| Electrocardiography | 10 | 2019 | 553 | 0.860 |
Why?
|
| Head and Neck Neoplasms | 2 | 2016 | 165 | 0.830 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2017 | 50 | 0.800 |
Why?
|
| Stroke Volume | 11 | 2018 | 338 | 0.790 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 260 | 0.780 |
Why?
|
| Echocardiography, Transesophageal | 10 | 2006 | 117 | 0.650 |
Why?
|
| Situs Inversus | 1 | 2019 | 5 | 0.610 |
Why?
|
| Dextrocardia | 1 | 2019 | 5 | 0.610 |
Why?
|
| Shock, Septic | 2 | 2019 | 88 | 0.560 |
Why?
|
| Pulmonary Embolism | 2 | 2017 | 194 | 0.540 |
Why?
|
| Aged | 43 | 2019 | 14834 | 0.530 |
Why?
|
| Systole | 7 | 2019 | 110 | 0.530 |
Why?
|
| Dilatation | 1 | 2016 | 34 | 0.500 |
Why?
|
| Hyperkalemia | 1 | 2016 | 20 | 0.500 |
Why?
|
| Medical Audit | 1 | 2016 | 66 | 0.490 |
Why?
|
| Risk Adjustment | 1 | 2016 | 94 | 0.490 |
Why?
|
| Humans | 70 | 2023 | 64729 | 0.490 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 42 | 0.480 |
Why?
|
| Potassium | 1 | 2016 | 97 | 0.480 |
Why?
|
| Pacemaker, Artificial | 2 | 2013 | 50 | 0.480 |
Why?
|
| Diastole | 7 | 2016 | 91 | 0.470 |
Why?
|
| Benchmarking | 1 | 2016 | 136 | 0.470 |
Why?
|
| Electroencephalography | 1 | 2016 | 149 | 0.470 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2023 | 44 | 0.450 |
Why?
|
| Female | 52 | 2020 | 33739 | 0.450 |
Why?
|
| Middle Aged | 37 | 2017 | 18106 | 0.430 |
Why?
|
| Heart Rate | 6 | 2012 | 330 | 0.430 |
Why?
|
| Takotsubo Cardiomyopathy | 4 | 2020 | 69 | 0.430 |
Why?
|
| Myocardial Infarction | 5 | 2015 | 917 | 0.420 |
Why?
|
| Male | 43 | 2019 | 30790 | 0.420 |
Why?
|
| Tracheostomy | 1 | 2014 | 36 | 0.410 |
Why?
|
| Heart Neoplasms | 5 | 2006 | 36 | 0.400 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 131 | 0.400 |
Why?
|
| Atrial Fibrillation | 4 | 2016 | 869 | 0.400 |
Why?
|
| Hepatic Veins | 1 | 2013 | 13 | 0.390 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2013 | 6 | 0.390 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 190 | 0.380 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1309 | 0.360 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 97 | 0.360 |
Why?
|
| Myocardial Contraction | 3 | 2009 | 88 | 0.360 |
Why?
|
| Algorithms | 2 | 2016 | 1033 | 0.350 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 2009 | 11 | 0.350 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 187 | 0.350 |
Why?
|
| Heart Atria | 6 | 2023 | 135 | 0.340 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 366 | 0.340 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 164 | 0.330 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2010 | 268 | 0.320 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 22 | 0.320 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2010 | 33 | 0.320 |
Why?
|
| Aortic Valve | 4 | 2011 | 181 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 97 | 0.310 |
Why?
|
| Metoprolol | 1 | 2009 | 17 | 0.310 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2006 | 25 | 0.310 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 152 | 0.300 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2002 | 42 | 0.290 |
Why?
|
| Blood Pressure | 4 | 2010 | 525 | 0.290 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 202 | 0.290 |
Why?
|
| Cardiac Catheterization | 4 | 2014 | 292 | 0.280 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2008 | 27 | 0.280 |
Why?
|
| Cardiac Volume | 1 | 2007 | 7 | 0.270 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 1689 | 0.270 |
Why?
|
| Ventricular Function | 1 | 2007 | 22 | 0.270 |
Why?
|
| Stress, Physiological | 2 | 2009 | 209 | 0.270 |
Why?
|
| Heart Failure | 7 | 2016 | 940 | 0.250 |
Why?
|
| Electric Countershock | 3 | 2015 | 105 | 0.240 |
Why?
|
| Hypertension | 2 | 2009 | 609 | 0.240 |
Why?
|
| Acute Coronary Syndrome | 1 | 2009 | 252 | 0.240 |
Why?
|
| Myxoma | 3 | 2006 | 14 | 0.240 |
Why?
|
| Sensitivity and Specificity | 7 | 2016 | 1159 | 0.240 |
Why?
|
| Heart Diseases | 3 | 2007 | 222 | 0.240 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 200 | 0.230 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 104 | 0.230 |
Why?
|
| United Kingdom | 2 | 2016 | 85 | 0.230 |
Why?
|
| Stress, Psychological | 2 | 2009 | 472 | 0.230 |
Why?
|
| Ventricular Remodeling | 3 | 2018 | 90 | 0.220 |
Why?
|
| Arrhythmia, Sinus | 1 | 2004 | 3 | 0.220 |
Why?
|
| Heart Block | 1 | 2004 | 21 | 0.220 |
Why?
|
| Retrospective Studies | 11 | 2018 | 6803 | 0.220 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2012 | 124 | 0.220 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 27 | 0.210 |
Why?
|
| Triglycerides | 1 | 2005 | 248 | 0.210 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 5562 | 0.200 |
Why?
|
| Heart Valve Prosthesis | 2 | 2002 | 106 | 0.200 |
Why?
|
| Viridans Streptococci | 1 | 2002 | 5 | 0.190 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 80 | 0.180 |
Why?
|
| Abscess | 1 | 2002 | 78 | 0.180 |
Why?
|
| Adult | 16 | 2016 | 17230 | 0.180 |
Why?
|
| Coronary Angiography | 4 | 2010 | 209 | 0.180 |
Why?
|
| Chest Pain | 2 | 2019 | 85 | 0.170 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2000 | 9 | 0.160 |
Why?
|
| Collateral Circulation | 1 | 2000 | 28 | 0.160 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.160 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 1999 | 2 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2004 | 58 | 0.160 |
Why?
|
| Risk Factors | 7 | 2016 | 5393 | 0.150 |
Why?
|
| Lymphoma | 1 | 2000 | 101 | 0.150 |
Why?
|
| Heart Aneurysm | 1 | 1999 | 23 | 0.150 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 27 | 0.150 |
Why?
|
| Aneurysm, False | 1 | 1999 | 47 | 0.150 |
Why?
|
| Heart Valves | 1 | 2018 | 26 | 0.140 |
Why?
|
| Aortic Diseases | 2 | 2011 | 65 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 117 | 0.140 |
Why?
|
| Aging | 2 | 2003 | 761 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2019 | 103 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2015 | 2086 | 0.140 |
Why?
|
| Ultrasonography | 4 | 2009 | 489 | 0.140 |
Why?
|
| Mitral Valve | 3 | 2004 | 126 | 0.140 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1999 | 98 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2016 | 5758 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 93 | 0.130 |
Why?
|
| Dobutamine | 2 | 1994 | 12 | 0.130 |
Why?
|
| Reference Values | 3 | 2007 | 328 | 0.130 |
Why?
|
| Prognosis | 5 | 2009 | 1770 | 0.130 |
Why?
|
| Cough | 1 | 2019 | 184 | 0.130 |
Why?
|
| Massachusetts | 7 | 2016 | 2137 | 0.130 |
Why?
|
| Thallium Radioisotopes | 3 | 1995 | 9 | 0.130 |
Why?
|
| Cardiomegaly | 1 | 2016 | 37 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 52 | 0.120 |
Why?
|
| Catheterization | 1 | 1997 | 111 | 0.120 |
Why?
|
| Mitoxantrone | 1 | 2016 | 16 | 0.120 |
Why?
|
| ROC Curve | 1 | 2016 | 292 | 0.120 |
Why?
|
| Incidence | 3 | 2016 | 1409 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 1996 | 34 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1997 | 66 | 0.120 |
Why?
|
| Mitral Valve Stenosis | 1 | 1995 | 14 | 0.120 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 4 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2016 | 1001 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 1994 | 15 | 0.110 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2014 | 22 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 135 | 0.110 |
Why?
|
| Tachycardia, Sinus | 1 | 1994 | 3 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 66 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 50 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 929 | 0.110 |
Why?
|
| Machine Learning | 1 | 2016 | 192 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1268 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 64 | 0.100 |
Why?
|
| Operative Time | 1 | 2014 | 91 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2015 | 136 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 369 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 191 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 285 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 118 | 0.100 |
Why?
|
| Prevalence | 4 | 2010 | 1432 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 78 | 0.100 |
Why?
|
| Device Removal | 1 | 2013 | 64 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 539 | 0.090 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 110 | 0.090 |
Why?
|
| Age Factors | 2 | 2014 | 1580 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 100 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2016 | 3299 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 273 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1656 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2009 | 2603 | 0.090 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 6 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 31 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2012 | 154 | 0.080 |
Why?
|
| Diclofenac | 1 | 2010 | 5 | 0.080 |
Why?
|
| Ibuprofen | 1 | 2010 | 17 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2010 | 65 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 120 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 989 | 0.080 |
Why?
|
| Angiocardiography | 1 | 2009 | 6 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 295 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 112 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2010 | 177 | 0.070 |
Why?
|
| Disease Progression | 3 | 2008 | 1210 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2014 | 2483 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1135 | 0.070 |
Why?
|
| Syndrome | 2 | 2006 | 178 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 281 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2011 | 1410 | 0.070 |
Why?
|
| Contrast Media | 1 | 2010 | 429 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 851 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 215 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1104 | 0.060 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2006 | 5 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 125 | 0.060 |
Why?
|
| Young Adult | 1 | 2016 | 4771 | 0.060 |
Why?
|
| Catecholamines | 1 | 2006 | 31 | 0.060 |
Why?
|
| Magnetics | 1 | 2005 | 53 | 0.060 |
Why?
|
| Ventricular Pressure | 1 | 2005 | 31 | 0.060 |
Why?
|
| Inpatients | 1 | 2008 | 310 | 0.060 |
Why?
|
| Time Factors | 3 | 2009 | 3745 | 0.060 |
Why?
|
| Patient Selection | 1 | 2007 | 483 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 706 | 0.060 |
Why?
|
| Video Recording | 1 | 2005 | 138 | 0.050 |
Why?
|
| Exercise Test | 3 | 1995 | 256 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 73 | 0.050 |
Why?
|
| Adenosine | 2 | 1995 | 78 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2005 | 497 | 0.050 |
Why?
|
| Pericarditis, Constrictive | 1 | 2003 | 3 | 0.050 |
Why?
|
| Coronary Disease | 2 | 2003 | 246 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2007 | 418 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2003 | 23 | 0.050 |
Why?
|
| Pericardium | 1 | 2023 | 35 | 0.050 |
Why?
|
| Hemodynamics | 4 | 2003 | 251 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 106 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 987 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2002 | 41 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2000 | 43 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1205 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1995 | 128 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2003 | 140 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 1995 | 123 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 1998 | 84 | 0.030 |
Why?
|
| Myocardial Stunning | 1 | 1996 | 6 | 0.030 |
Why?
|
| Child | 2 | 2011 | 4599 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 58 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 80 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 59 | 0.030 |
Why?
|
| Electrodes | 1 | 1996 | 39 | 0.030 |
Why?
|
| Length of Stay | 2 | 2010 | 822 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2680 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 1555 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1994 | 77 | 0.030 |
Why?
|
| Perfusion | 1 | 1994 | 74 | 0.030 |
Why?
|
| Linear Models | 1 | 1995 | 406 | 0.030 |
Why?
|
| Heart | 1 | 1996 | 295 | 0.030 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 292 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 847 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2013 | 26 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1994 | 116 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1115 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2012 | 39 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 173 | 0.020 |
Why?
|
| Acute Disease | 1 | 1994 | 665 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1992 | 70 | 0.020 |
Why?
|
| Biomarkers | 2 | 2010 | 1465 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 640 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 655 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 135 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 171 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 106 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 164 | 0.020 |
Why?
|
| Oxygen | 1 | 1991 | 317 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 451 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 745 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 583 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 222 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 190 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2006 | 48 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 128 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 575 | 0.020 |
Why?
|
| Reoperation | 1 | 2006 | 296 | 0.010 |
Why?
|
| Midazolam | 1 | 2004 | 12 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 179 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 1995 | 34 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 39 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 2004 | 25 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 159 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 214 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2004 | 35 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 66 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 321 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 9 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2003 | 42 | 0.010 |
Why?
|
| Rhabdomyolysis | 1 | 2003 | 23 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 36 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 129 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 146 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 18 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 298 | 0.010 |
Why?
|
| Venae Cavae | 1 | 1998 | 2 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1998 | 34 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 171 | 0.010 |
Why?
|
| Thrombosis | 1 | 1998 | 205 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1995 | 67 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 313 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 414 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1994 | 5 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1994 | 35 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1994 | 54 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 175 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 734 | 0.010 |
Why?
|
| Forecasting | 1 | 1994 | 229 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1991 | 14 | 0.010 |
Why?
|
| Peritonitis | 1 | 1991 | 43 | 0.010 |
Why?
|
| Swine | 1 | 1991 | 394 | 0.000 |
Why?
|
| United States | 1 | 2003 | 8041 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 21292 | 0.000 |
Why?
|